Nipent is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Pentostatin.
Product ID | 0409-0801_8fa82560-cea4-4272-9ae0-c97ac1635c8b |
NDC | 0409-0801 |
Product Type | Human Prescription Drug |
Proprietary Name | Nipent |
Generic Name | Pentostatin |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2007-08-15 |
Marketing Category | NDA / NDA |
Application Number | NDA020122 |
Labeler Name | Hospira, Inc. |
Substance Name | PENTOSTATIN |
Active Ingredient Strength | 2 mg/mL |
Pharm Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2007-08-15 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020122 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2007-08-15 |
Marketing End Date | 2016-10-01 |
Marketing Category | NDA |
Application Number | NDA020122 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2007-08-15 |
Ingredient | Strength |
---|---|
PENTOSTATIN | 2 mg/mL |
SPL SET ID: | 674e0e6d-46ed-4868-9196-04019d667716 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0409-0801 | Nipent | PENTOSTATIN |
67457-288 | Pentostatin | Pentostatin |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
NIPENT 74172705 1730233 Live/Registered |
HOSPIRA, INC. 1991-06-03 |